Hi-Tech Pharmacal (HITK) is scheduled as one of the last companies to post a quarterly report this earnings season. However, if its quarterly report in December is any indication, this pick's earnings are well worth waiting for.

In its previous report, Hi-Tech's earnings rose 566.7% to $7.4 million, or 60 cents per share, compared with $1.1 million, or 9 cents per share, in the same quarter a year ago, while sales rose 62.9% in the same period.

The market's rebound after a rough start to February has proven that this bull market still has some legs. But I must warn you that not all stocks are set to share in the profits.

The bearish analysts like to hold up the trouble for a few big-name blue chips as a sign that market is doomed -- but don't believe it. These naysayers who focus on the short-lived dips or handful of problem companies forget this is a market of stocks and not just a stock market.

The fact is that there are a lot of smaller companies that are thriving right now even if the 30 components of the Dow are struggling.

In last week's preview we took a peek at expectations for Campbell Soup earnings, but now the company is scheduled to report fiscal fourth quarter results this coming Thursday. With Krispy Kreme also among the handful of companies scheduled to report this week, we may yet see whether consumers are turning to comfort foods in these uncertain times.

Campbell Soup Co. (NYSE: CPB), the world's biggest soup maker, is still expected by analysts surveyed by Thomson Financial to post net income of 25 cents per share (up 44.0% from a year ago) on revenue of $1.7 billion (up 7.4%). The Camden, N.J.-based company has just missed earnings estimates in the past few quarters. Its long-term EPS growth forecast is 7.9%, which is less than the industry average, but about the same as rivals Kraft Foods (NYSE: KFT) and HJ Heinz (NYSE: HNZ). The analysts' consensus recommendation is currently to buy Campbell.

Hip, Canadian apparel retailer Lululemon Athletica Inc. (NASDAQ: LULU) is also anticipated to be a big earnings gainer when it reports this week. Net income is expected to come in at 13 cents per share (up 46.2% from a year ago) on revenue of $88.2 million (up 50.3%). Lululemon met expectations when it reported 12 cents per share in the previous quarter. Its long-term EPS growth forecast is a healthy 40.2%, which is better than the industry average and that of rival Under Armour Inc. (NYSE: UA). The analysts' consensus recommendation is currently to buy Lululemon.